Progression-Free Survival but Not Overall Survival Is Superior in Relapsed/Refractory Large B-Cell Lymphomas Treated with Axicabtagene Ciloleucel Compared to Tisagenlecleucel: Results of the CART-SIE Real Life Italian StudyAnnalisa Chiappella,Anna Dodero,Beatrice Casadei,Chiara De Philippis,Silva Ljevar,Eugenio Galli,Alice Di Rocco, Matteo Giovanni Carrabba,Maria Chiara Tisi,Maurizio Musso,Ilaria Cutini,Anna Maria Barbui,Mirko Farina,Massimo Martino,Anna Guidetti,Barbara Botto,Giovanni Grillo,Jacopo Olivieri,Martina Pennisi,Mauro Krampera,Marco Ladetto,Massimo Massaia,Luca Arcaini,Federica Cavallo,Rosalba Miceli,Maurizio Martelli,Patrizia Chiusolo,Stefania Bramanti,Pier Luigi Zinzani,Paolo CorradiniBLOOD（2023）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
